Post-traumatic and post-procedural scars: what the data shows about Mimosa Tenuiflora
Posted by Rucsandra Hurezeanu
From a dermatological perspective, a scar is not an isolated aesthetic defect, but the visible result of a biological process: cutaneous healing. How we intervene in the first few weeks after an injury, surgical intervention, or a dermato-aesthetic procedure directly influences the quality of the resulting tissue. In this article, I review the mechanism of action of Mimosa Tenuiflora, the central ingredient in the Cicaderm range, the types of scars that respond to topical treatment, and the optimal window for intervention.
In short:
Mimosa Tenuiflora: from ethnobotany to clinical dermatology
Mimosa Tenuiflora is a tree species native to Central America, traditionally called the "skin tree" due to the use of its bark in treating wounds. The interest of modern dermatology in this extract has been supported by extensive clinical observations: following industrial explosions and the earthquake in Mexico in the 80s, in a context of limited medical resources, intervention teams applied bark extract directly to severe burns. The Mexican Red Cross reported a drop in mortality from 20% to 4% among the treated patients, along with a reduced incidence of visible scarring. These observations subsequently motivated phytochemical research into the active compounds in Mimosa Tenuiflora bark—tannins, saponins, and flavonoid compounds with anti-inflammatory roles that promote re-epithelialization.
The mechanism of action in the cutaneous healing process
Wound healing goes through three overlapping phases: the inflammatory phase, the proliferative phase, and the remodeling phase. A scar becomes visible when, usually during the proliferative phase, collagen synthesis is disorganized or excessive. Mimosa Tenuiflora extract intervenes at this level by stimulating the activity of fibroblasts—the cells responsible for producing collagen and the extracellular matrix—supporting the formation of new, better-organized tissue instead of disorganized fibrous tissue. The anti-inflammatory component of the extract simultaneously reduces local irritation throughout the healing process, a factor that influences both patient comfort and the final quality of the scar.
From a clinical standpoint, this mechanism explains why results are dependent on the timing of the intervention: the closer topical treatment starts to the closure of the wound, the greater the influence on the architecture of the newly formed tissue.
Which types of scars respond best to topical treatment
Based on clinical experience and specialized literature, receptivity to treatment varies depending on the age and type of the scar:
Recent, erythematous scars – have the best response; consistent application can visibly reduce erythema in a few weeks.
Old, matured, pearly-white scars – respond slowly and incompletely to topical treatment, as the collagen architecture is already stabilized.
Post-acne lesions and post-inflammatory hyperpigmentation – improve progressively with sustained daily application.
Keloid scars do not fall into this category—they require dedicated dermatological evaluation, as topical treatment alone is not sufficient.
The therapeutic window: when and how to apply the treatment
The starting moment is just as important as the chosen product. The clinical rule is simple: do not apply a scarring cream to an open wound. As long as the skin is still exudative, a spray format is indicated, which does not require friction-based contact; the cream should only be introduced after the wound has completely closed, when the surface is no longer moist.
The recommended protocol is application twice a day, morning and evening, on clean skin, for at least a few consecutive weeks—the minimum duration required for collagen remodeling to produce a visible result. Photoprotection of the treated area is a mandatory step: exposure to UV radiation during the scar maturation period can cause persistent hyperpigmentation of the newly formed tissue.
The Cicaderm formula: composition and clinical data
Cicaderm Repair cream combines Mimosa Tenuiflora bark extract with Herculane Thermal Water and copper and zinc sulfate, which have a reparative role and balance the local cutaneous flora. It is indicated for cuts, superficial burns, and dermato-aesthetic procedures.
In an in vivo clinical study conducted on 20 patients post-dermato-cosmetic procedure, the appearance of the lesions improved significantly within 14 days of application, and skin tolerance was rated as excellent by all participants. The texture of the formula is adapted for limited treatment areas and for dry or sensitized skin.
In vivo study on 20 patients after dermato-cosmetic procedures, 2018.
Frequently asked questions
Yes, on closed surgical scars. Application begins only after the doctor confirms complete wound healing.
Yes, in the case of recent marks and post-inflammatory hyperpigmentation, with consistent application. Deep atrophic scars require dedicated dermatological procedures.
Texture and local comfort can improve, but the result is limited compared to intervention on a recent scar.
Yes, on small areas and on clean skin.
Yes, after complete absorption of the cream—it is recommended to wait a few minutes before applying foundation.
Yes, for small residual lesions, provided early and consistent application.
Dr. Rucsandra Hurezeanu
Physician, CEO & Founder of Ivatherm
Echipa Ivatherm
Conținutul IvaStories este creat de echipa Ivatherm, brand romanesc de dermatocosmetice fondat de Dr. Rucsandra Hurezeanu. Produsele Ivatherm sunt formulate cu Apă Termală Herculane și sunt testate dermatologic, recomandate de medici specialiști.
Post-traumatic and post-procedural scars: what the data shows about Mimosa Tenuiflora
In short:
Mimosa Tenuiflora: from ethnobotany to clinical dermatology
Mimosa Tenuiflora is a tree species native to Central America, traditionally called the "skin tree" due to the use of its bark in treating wounds. The interest of modern dermatology in this extract has been supported by extensive clinical observations: following industrial explosions and the earthquake in Mexico in the 80s, in a context of limited medical resources, intervention teams applied bark extract directly to severe burns. The Mexican Red Cross reported a drop in mortality from 20% to 4% among the treated patients, along with a reduced incidence of visible scarring. These observations subsequently motivated phytochemical research into the active compounds in Mimosa Tenuiflora bark—tannins, saponins, and flavonoid compounds with anti-inflammatory roles that promote re-epithelialization.
The mechanism of action in the cutaneous healing process
Wound healing goes through three overlapping phases: the inflammatory phase, the proliferative phase, and the remodeling phase. A scar becomes visible when, usually during the proliferative phase, collagen synthesis is disorganized or excessive. Mimosa Tenuiflora extract intervenes at this level by stimulating the activity of fibroblasts—the cells responsible for producing collagen and the extracellular matrix—supporting the formation of new, better-organized tissue instead of disorganized fibrous tissue. The anti-inflammatory component of the extract simultaneously reduces local irritation throughout the healing process, a factor that influences both patient comfort and the final quality of the scar.
From a clinical standpoint, this mechanism explains why results are dependent on the timing of the intervention: the closer topical treatment starts to the closure of the wound, the greater the influence on the architecture of the newly formed tissue.
Which types of scars respond best to topical treatment
Based on clinical experience and specialized literature, receptivity to treatment varies depending on the age and type of the scar:
Keloid scars do not fall into this category—they require dedicated dermatological evaluation, as topical treatment alone is not sufficient.
The therapeutic window: when and how to apply the treatment
The starting moment is just as important as the chosen product. The clinical rule is simple: do not apply a scarring cream to an open wound. As long as the skin is still exudative, a spray format is indicated, which does not require friction-based contact; the cream should only be introduced after the wound has completely closed, when the surface is no longer moist.
The recommended protocol is application twice a day, morning and evening, on clean skin, for at least a few consecutive weeks—the minimum duration required for collagen remodeling to produce a visible result. Photoprotection of the treated area is a mandatory step: exposure to UV radiation during the scar maturation period can cause persistent hyperpigmentation of the newly formed tissue.
The Cicaderm formula: composition and clinical data
Cicaderm Repair cream combines Mimosa Tenuiflora bark extract with Herculane Thermal Water and copper and zinc sulfate, which have a reparative role and balance the local cutaneous flora. It is indicated for cuts, superficial burns, and dermato-aesthetic procedures.
In an in vivo clinical study conducted on 20 patients post-dermato-cosmetic procedure, the appearance of the lesions improved significantly within 14 days of application, and skin tolerance was rated as excellent by all participants. The texture of the formula is adapted for limited treatment areas and for dry or sensitized skin.
In vivo study on 20 patients after dermato-cosmetic procedures, 2018.
Frequently asked questions
Yes, on closed surgical scars. Application begins only after the doctor confirms complete wound healing.
Yes, in the case of recent marks and post-inflammatory hyperpigmentation, with consistent application. Deep atrophic scars require dedicated dermatological procedures.
Texture and local comfort can improve, but the result is limited compared to intervention on a recent scar.
Yes, on small areas and on clean skin.
Yes, after complete absorption of the cream—it is recommended to wait a few minutes before applying foundation.
Yes, for small residual lesions, provided early and consistent application.
Dr. Rucsandra Hurezeanu
Physician, CEO & Founder of Ivatherm
Echipa Ivatherm
Conținutul IvaStories este creat de echipa Ivatherm, brand romanesc de dermatocosmetice fondat de Dr. Rucsandra Hurezeanu. Produsele Ivatherm sunt formulate cu Apă Termală Herculane și sunt testate dermatologic, recomandate de medici specialiști.